Collegium Pharmaceutical, Inc. (COLL) ownership: insiders 13% · institutions 119% (13F 2026-03-31). Insider activity, 90 days: 0 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 5134027.00 | $169.78M | 15.8% | 2026-03-31 |
| Vanguard | 2283008.00 | $75.50M | 7.0% | 2026-03-31 |
| Janus Henderson | 1825651.00 | $60.36M | 5.6% | 2026-03-31 |
| Invesco | 1591909.00 | $52.64M | 4.9% | 2026-03-31 |
| Fuller & Thaler Asset Management, Inc. | 1499584.00 | $49.59M | 4.6% | 2026-03-31 |
| Renaissance Technologies | 1469449.00 | $48.59M | 4.5% | 2026-03-31 |
| State Street | 1424544.00 | $47.11M | 4.4% | 2026-03-31 |
| Eventide Asset Management, LLC | 1424282.00 | $47.08M | 4.4% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-14 |
Back to COLL overview · COLL earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.